- Home
- OFLX vs AQST Comparison
OFLX vs AQST Comparison
Compare OFLX & AQST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OFLX
- AQST
- Stock Information
- Founded
- OFLX 1975
- AQST 2004
- Country
- OFLX United States
- AQST United States
- Employees
- OFLX N/A
- AQST N/A
- Industry
- OFLX Industrial Specialties
- AQST Biotechnology: Pharmaceutical Preparations
- Sector
- OFLX Industrials
- AQST Health Care
- Exchange
- OFLX Nasdaq
- AQST Nasdaq
- Market Cap
- OFLX 344.9M
- AQST 390.4M
- IPO Year
- OFLX 2005
- AQST 2018
- Fundamental
- Price
- OFLX $32.87
- AQST $4.11
- Analyst Decision
- OFLX
- AQST Strong Buy
- Analyst Count
- OFLX 0
- AQST 6
- Target Price
- OFLX N/A
- AQST $10.67
- AVG Volume (30 Days)
- OFLX 24.9K
- AQST 1.2M
- Earning Date
- OFLX 07-30-2025
- AQST 08-11-2025
- Dividend Yield
- OFLX 4.14%
- AQST N/A
- EPS Growth
- OFLX N/A
- AQST N/A
- EPS
- OFLX 1.69
- AQST N/A
- Revenue
- OFLX $100,700,000.00
- AQST $44,132,000.00
- Revenue This Year
- OFLX N/A
- AQST N/A
- Revenue Next Year
- OFLX N/A
- AQST $51.62
- P/E Ratio
- OFLX $19.49
- AQST N/A
- Revenue Growth
- OFLX N/A
- AQST N/A
- 52 Week Low
- OFLX $28.12
- AQST $2.12
- 52 Week High
- OFLX $57.81
- AQST $5.80
- Technical
- Relative Strength Index (RSI)
- OFLX 48.20
- AQST 58.49
- Support Level
- OFLX $31.45
- AQST $3.69
- Resistance Level
- OFLX $34.44
- AQST $4.24
- Average True Range (ATR)
- OFLX 1.56
- AQST 0.24
- MACD
- OFLX 0.09
- AQST -0.01
- Stochastic Oscillator
- OFLX 65.03
- AQST 72.41
About OFLX Omega Flex Inc.
Omega Flex Inc is a manufacturer of flexible metal hoses, which is used in a variety of ways to carry gases and liquids within their particular applications. Omega sells its products under the TracPipe, CounterStrike, DoubleTrac, DEF-Trac and MediTrac brands. It serves various markets which include construction, manufacturing, transportation, petrochemical, pharmaceutical, and other industries. Geographically Omega Flex, Inc operates in the United States. The company derives revenues from the manufacture and sale of flexible metal hose and accessories.
About AQST Aquestive Therapeutics Inc.
Aquestive Therapeutics Inc is a specialty pharmaceutical company engaged in developing and commercializing differentiated products to meet medical needs. Its later-stage product pipeline focuses on the treatment of diseases of the Central Nervous System (CNS), and an earlier-stage pipeline for the treatment of severe allergic reactions, including anaphylaxis. Its commercial product portfolio includes Suboxone, Emylif, Ondif and Sympazan. The product pipeline includes Libervant Buccal Film, AQST-108. The majority of its revenue comes from the United States.